MedTrace Logo

Validity and Reliability of High-Activity Arthroplasty Score

NCT05211310 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 70

Last updated 2023-12-27

No results posted yet for this study

Summary

Patient-reported Outcome Measures (PROMs) used in total knee arthroplasty focus more on quality of life and pain. For this reason, individuals who can perform activities of daily living normally can get full points. There is a need for PROMs used in the assessment of higher functional skills. This study aimed to translate The High-Activity Arthroplasty Score (HAAS) into Turkish and to conduct a validity and reliability study of the Turkish version.

Conditions

  • Arthroplasty Complications

Interventions

OTHER

High-Activity Arthroplasty Score (HAAS)

The questionnaire developed by Talbot et al. in 2010 consists of 4 sub-dimensions. 0-18 points can be obtained from the survey. High scores are associated with higher functional ability.

OTHER

Western Ontario and McMaster Universities osteoarthritis score (WOMAC)

It is used to evaluate disability in patients with hip and knee osteoarthritis. Each sub-dimension is standardized within the range of 0-100 points, with high scores indicating poor health.

OTHER

The Knee injury and Osteoarthritis Outcome Score (KOOS)

It is calculated between 0 and 100 points. 0 points indicate severe knee problem, 100 points no knee problem

OTHER

The Forgotten Joint Score-12 (FJS-12)

It evaluates how much an individual can forget an artificial joint during activities of daily living. A total of 100 points can be obtained. A high score is associated with the ability to forget.

OTHER

EQ-5D-5L

It is a questionnaire evaluating the quality of life. The higher the total score, the higher the quality of life.

OTHER

Numerical pain scale (NPS)

It is the numerical expression of perceived pain intensity. It is rated from 0-10 points. 10 points indicate the highest pain intensity, 0 points the absence of pain.

Sponsors & Collaborators

  • Afyonkarahisar Health Sciences University

    lead OTHER

Principal Investigators

  • EMEL TAŞVURAN HORATA, PhD · AFSU

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-05-01
Primary Completion
2025-12-01
Completion
2025-12-01

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05211310 on ClinicalTrials.gov